CVS Health Corporation logo

CVS Health Corporation (CVS)

Market Open
3 Mar, 17:13
NYSE NYSE
$
80. 07
-1.59
-1.95%
$
96.93B Market Cap
11.4 P/E Ratio
0.97% Div Yield
2,660,269 Volume
7.87 Eps
$ 81.66
Previous Close
Day Range
79.13 81.67
Year Range
58.35 85.15
Want to track CVS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
CVS earnings report is expected in 57 days (29 Apr 2026)
CVS Health (CVS) Increases Despite Market Slip: Here's What You Need to Know

CVS Health (CVS) Increases Despite Market Slip: Here's What You Need to Know

In the latest trading session, CVS Health (CVS) closed at $77.9, marking a +1.51% move from the previous day.

Zacks | 4 months ago
CVS says over 81% of members are in high-rated Medicare Advantage plans for 2026

CVS says over 81% of members are in high-rated Medicare Advantage plans for 2026

CVS Health said on Thursday that its Aetna insurance business has over 81% of members in Medicare Advantage plans that are rated 4 stars or higher for 2026.

Reuters | 4 months ago
CVS Health (CVS) Is Considered a Good Investment by Brokers: Is That True?

CVS Health (CVS) Is Considered a Good Investment by Brokers: Is That True?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Zacks | 4 months ago
CVS Health (CVS) Exceeds Market Returns: Some Facts to Consider

CVS Health (CVS) Exceeds Market Returns: Some Facts to Consider

CVS Health (CVS) reached $76.87 at the closing of the latest trading day, reflecting a +1.96% change compared to its last close.

Zacks | 5 months ago
CVS Health: A Deeply Undervalued Giant Investors Keep Ignoring

CVS Health: A Deeply Undervalued Giant Investors Keep Ignoring

CVS Health remains a solid, undervalued business, despite recent underperformance, versus the S&P 500 and ongoing margin pressures. Q2/25 results showed strong revenue growth but declining operating income and earnings, with updated guidance raising adjusted EPS expectations for 2025. Intrinsic value calculations suggest CVS Health is deeply undervalued, with a realistic fair value estimate of $135 per share, offering significant upside.

Seekingalpha | 5 months ago
Why CVS Health (CVS) is a Top Value Stock for the Long-Term

Why CVS Health (CVS) is a Top Value Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 5 months ago
Jim Cramer Says This “Ridiculously Cheap” Healthcare Stock is a Buy

Jim Cramer Says This “Ridiculously Cheap” Healthcare Stock is a Buy

Healthcare investing has felt like walking through quicksand this year.

247wallst | 6 months ago
CVS Health Corporation (CVS) Hit a 52 Week High, Can the Run Continue?

CVS Health Corporation (CVS) Hit a 52 Week High, Can the Run Continue?

CVS Health (CVS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Zacks | 6 months ago
CVS Health Corporation (CVS) Is a Trending Stock: Facts to Know Before Betting on It

CVS Health Corporation (CVS) Is a Trending Stock: Facts to Know Before Betting on It

Zacks.com users have recently been watching CVS Health (CVS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Zacks | 6 months ago
CVS vs. ELV: Which Healthcare Titan Is the Stronger Investment Today?

CVS vs. ELV: Which Healthcare Titan Is the Stronger Investment Today?

CVS Health advances with Aetna margin recovery, digital investments and cost savings, making it the stronger healthcare bet over Elevance.

Zacks | 6 months ago
CVS Health Services' Q2 AOI Falls Despite Sales Gain: More Risk Ahead?

CVS Health Services' Q2 AOI Falls Despite Sales Gain: More Risk Ahead?

CVS Health's Q2 Health Services revenues climb 10%. Yet, AOI slips as cost pressures and Oak Street's rising MBR ail.

Zacks | 6 months ago
Jim Cramer talks what is driving CVS higher this year

Jim Cramer talks what is driving CVS higher this year

'Mad Money' host Jim Cramer takes a look at CVS and what is driving the stock up.

Youtube | 6 months ago
Loading...
Load More